Company intelligence / Profile preview

X-act Cologne Clinical Research

Cologne, North Rhine-Westphalia, Germany

Ownership: Private
Employees: ~35
Development stage: Other

Overview

X-act Cologne Clinical Research specializes in clinical data management and biostatistics, supporting more than 450 studies with expertise across interventional (Phase I–IV), non-interventional, and medical device clinical trials. The company acts as a CRO and clinical service provider, rather than directly developing drugs. It has supported Phase 2 oncology trials on copanlisib dihydrochloride and rituximab in marginal zone B-cell lymphoma.

Therapeutic areas: Oncology
Modalities: Small moleculeMonoclonal antibody
Industry: Contract Research Organization

Partnerships

Universität Ulm

Beyond the preview

Go deeper on X-act Cologne Clinical Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on X-act Cologne Clinical Research.

Explore the full profile